Insights into Company Bills & Payments

Pakka Limited

📍 Kanpur, Uttar Pradesh, India Active NSE PAKKA CIN L24231UP1981PLC005294
Search companies

Key Metrics of Pakka Limited

Revenue₹356 Cr▼ 12.4% YoYFY 2025-26
EBITDA₹53.1 Cr▼ 43.1% YoY
Net profit₹23.5 Cr▼ 58.5% YoY
Net worth₹506 Cr▲ 3.8% YoY

About Pakka Limited

Company details

Registered office
312, Plaza Kalpana Society,24/147, B-49,, Kanpur Nagar, Birhana Road, Uttar Pradesh, India,, Kanpur, In-up, 208001
Listed
NSE: PAKKA · ₹70.56

Company summary

Entity details

CINL24231UP1981PLC005294
LEI code335800FTBEHFZ7XQCI90
State codeUP
PIN code208001
Current legal namePAKKA LIMITED
Classification—
Listing statusListed (NSE: PAKKA)
Registration no.005294
Company age—
PAN—
CountryIndia
CityKanpur
StateUttar Pradesh
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code24231
Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
SectorOther Industries · Discovered Companies

Share price · NSE: PAKKA

PAKKA on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 1 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 31 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 09 Jun 2026 CARE BB+ Stable outlook · Short term A4+ · Downgraded
Change in last 12 months▼ 2 notches
Change since first rating on record▼ 1 notchsince Nov 2017
Rating actions130 up · 2 down
Liquidity (CARE)Adequate

WatchDowngraded by CARE on 09 Jun 2026 (from BBB-)

WatchIssuer not cooperating with CARE (rating based on limited information)

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
09 Jun 2026CAREDowngraded (from BBB-) BB+A4+Stable₹631 Cr View
06 Mar 2026CAREDowngraded (from BBB) BBB-—Negative₹631 Cr View
29 Apr 2025CAREReaffirmed BBBA3+Stable₹631 Cr View
06 Jan 2025CAREWatch BBB—Stable₹469 Cr View
07 Mar 2024CAREWatch BBBA3+Developing₹469 Cr View
06 Apr 2023CAREReaffirmed BBBA3+Stable₹478 Cr View
16 Feb 2023CAREAssigned BBBA3+Stable₹162 Cr View
30 Jul 2021CAREWithdrawn BBB—Stable— View
03 Feb 2021CARENon-cooperating BBBA3Stable₹410 Cr View
22 Jan 2020CAREReaffirmed BBBA3Stable₹205 Cr View
04 Oct 2018CAREReaffirmed (from BBB) BBBA3Stable₹404 Cr View
04 Dec 2017CAREReaffirmed BBB-A3Stable₹165 Cr View
17 Nov 2017CAREAssigned BBB-A3Stable₹165 Cr View

Credit strengths (CARE, Jun 2026)

+ Experienced and professional management team with long track record of operations

Pakka Limited, formerly known as Yash Pakka Limited until July 06, 2023, was founded in 1981 by late KK Jhunjhunwala. The company is currently managed by Ved Krishna, Managing Director, with over 25 years of industry experience and overseeing the company’s overall operations and the help of professionals. The company has a long -standing presence in the paper packaging industry, spanning over four decades, which has helped in establishing long -standing business relationships with customers.

+ Locational advantages in form of easy raw material availability

The primary raw material, bagasse, used by the company in its manufacturing process is agro based. The plant is in Uttar Prad esh, which is the sugarcane hub of India, ensuring ample bagasse availability. Pakka Limited procures its bagasse fibre requiremen t from a 100-km radius, ensuring reliable and consistent supply. The company also benefits from long -term contracts with these suppliers, which enhances its supply chain efficiency.

+ Cost-effective production set-up with integrated operations

The paper packaging industry is capital and energy intensive. The company has set up a cost -effective production mechanism that comprises a captive power plant using rice husk with a capacity of 8.8 MW that addresses its major power requirement and reduces power cost, and an integrated soda recovery plant with a capacity of 145 MTPD that recovers caustic soda and reduces chemical cost. Pakka Limited is increasing the capacity of its captive power plant to 15 MW to cater to the steam and power

+ Liquidity: Adequate

The liquidity position of the company remains adequate as reflected by projected GCA of ~₹42.78 crore in FY26 against scheduled repayment of ₹13.02 crore. The company has free cash and bank balance of ₹15.00 crore as on December 31, 2025, andaverage utilisation of fund-based working capital limits (based on maximum level) remained at ~84% in the past 12 month’s period ending December 2025. Optimal utilisation of PM3 and the timely implementation and stabilisation of PM4 will remain critical for

+ Assumptions/Covenants: Not applicable

Environment, social, and governance (ESG) risks: Not applicable Applicable criteria Definition of Default Information Adequacy Risk and Issuer Non -Cooperation Liquidity Analysis of Non-Financial Sector Entities Rating Outlook and Rating Watch Manufacturing Companies

+ Brief Financials (₹ crore) March 31, 2025 (A) March 31, 2026 (UA)

Total operating income 411.20 355.80 PBILDT* 82.45 42.15 Profit after tax (PAT) 56.70 18.15 Overall gearing (x) 0.42 0.91 Interest coverage (x) 8.00 3.70 A: Audited UA: Unaudited; Note: these are latest available financial results *PBILDT: Profit before interest, lease rentals, depreciation and tax

Credit challenges

− Cost and time overrun in project Jagriti with debt refinancing at high interest rates

Pakka Limited is undertaking a large capex of ₹676.26 crore equivalent to 1.34x of its tangible net worth (TNW) as on March 31, 2026, which is spread over FY24-FY26 (refers to April 01, 2023, to March 31, 2026). Capex aims to expand the company’s production capacity from 130 metric tonne per day (MTPD) to 246 MTPD through installation of a new PM4 of 100 MTPD capacity, 10 MTPD increase in the existing paper mill, and an upgrade of the pulp mill to increase bleached capacity to 180 MTPD from 130

− Project implementation and stabilisation risk

The company incurred ₹465.41 crore of project cost (~62.56% of the total capex of ₹744.00 cror e) as on December 31, 2025, funded through a mix of debt of ₹218.28 crore and balance from equity and internal accruals. Further, as per latest Lender’s Independent Engineer (LIE) report dated December 2025, the company achieved physical progress of 57.61% , financial progress of 69.36% and obtained all “pre -establishment” approvals required for the project. CareEdge Ratings notes a significant fall i

− Operational disruptions impacted FY26 performance

In FY26, total operating income (TOI) moderated to ₹355.80 crore from ₹411.20 crore in FY25, primarily due to reduction in net sales realisations (NSR) across the industry. As part of the phased rollout under project Jagriti, which includes expansion of PM3 and pulp machine, the company undertook a planned shutdown of its manufacturing unit from June 16, 2025, to July 24, 2025. This shutdown led to nil pulp sales in the period, adversely affecting revenue and profit margins in Q1FY26 and Q2FY26.

− Highly fragmented and competitive industry with raw material price volatility

The paper packaging industry is highly competitive with intense competition from organised and unorganised players. This limi ts pricing power of the manufacturers and puts pressure on profitability. Pakka Limited uses agro -based raw material, procured primarily from the domestic markets and subject to seasonal availability that leads to high price volatility. The operating profitability of the company remains highly susceptible to raw material price volatility. Also, the paper packaging indust

− Key strengths

Experienced and professional management team with long track record of operations Pakka Limited, formerly known as Yash Pakka Limited until July 06, 2023, was founded in 1981 by late KK Jhunjhunwala. The company is currently managed by Ved Krishna, Managing Director, with over 25 years of industry experience and overseeing the company’s overall operations and the help of professionals. The company has a long -standing presence in the paper packaging

− Locational advantages in form of easy raw material availability

The primary raw material, bagasse, used by the company in its manufacturing process is agro based. The plant is in Uttar Prad esh, which is the sugarcane hub of India, ensuring ample bagasse availability. Pakka Limited procures its bagasse fibre requiremen t from a 100-km radius, ensuring reliable and consistent supply. The company also benefits from long -term contracts with these suppliers, which enhances its supply chain efficiency.

Could lead to an upgrade

• Improvement in scale of operations to ~₹600.00 crore and maintenance of profit before interest, lease rentals, depreciation and taxation (PBILDT) margin above 20% on a sustained basis. • Sustained improvement in operational cash flows to maintain healthy

Could lead to a downgrade

• Significant decline in scale of operations with the PBILDT margin below 20% in future years (excluding FY26). • Any higher-than-envisaged debt-funded capex/advances to group entities adversely affecting capital structure, leading to overall gearing above 1.50x. • Any further delay in COD of project Jagriti or lower-than-envisaged cash flow from operations adversely affecting

Agency-reported financials (CARE, 09 Jun 2026)

MetricMarch 31, 2025March 31, 2026
Total operating income₹411 Cr₹356 Cr
PBILDT*₹82.45 Cr₹42.15 Cr
Profit after tax (PAT)₹56.70 Cr₹18.15 Cr
Overall gearing (x)0.42×0.91×
Interest coverage (x)8.00×3.70×
Revenue growth (YoY)—−13.5%
PAT margin13.8%5.1%

Borrowings & rated debt

Rated borrowing limits (latest)₹631 Cr
Peak rated limits₹631 CrApr 2025 · CARE
Limits raised0 times4 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
ISSUER Long-term bank facilitiesWorking capital & bank lines—₹618 Cr— BB+ (Stable)DowngradedCARE
NOT ISSUER NOT ISSUER Short-term bank facilitiesWorking capital & bank lines—₹12.5 Cr— A4+DowngradedCARE

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
Bank Guarantee—Withdrawn
BG/LC—Withdrawn
BG/LC₹12.5 CrCARE A4+; ISSUER NOT COOPERATING*
Cash Credit—Withdrawn
Term Loan—Withdrawn
Term Loan₹484 CrCARE BB+; Stable; ISSUER NOT COOPERATING*
Working Capital Limits₹135 CrCARE BB+; Stable; ISSUER NOT COOPERATING*

Lenders

Fund-based - LTTerm LoanAditya Birla Finance Ltd.
Fund-based - LTTerm LoanAxis Bank Ltd.
Fund-based - LTTerm LoanCanara Bank
Fund-based - LTTerm LoanExport Import Bank of India
Fund-based - LTTerm LoanProposed
Fund-based - LTWorking Capital LimitsAxis Bank Ltd.
Fund-based - LTWorking Capital LimitsBank of Baroda
Fund-based - LTWorking Capital LimitsHDFC Bank Ltd.
Fund-based - LTWorking Capital LimitsUCO Bank
Non-fund-based - STBG/LCAxis Bank Ltd.
Non-fund-based - STBG/LCHDFC Bank Ltd.
Non-fund-based - STBG/LCUCO Bank

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStretchedAgency: Adequate
DirectionNegativeAgency outlook: Stable
CARE rating · Jun 2026BB+2 notches below indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationNot cooperating since 09 Jun 2026 (4 months)
Credit enhancementNone – standalone rating
WithdrawalCARE · 30 Jul 2021 · Withdrawn (reason not stated in report)
Next action stable or better (model)79%
Information on file89% · missing: Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 79% (Mostly stable) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹631 Cr
Not yet allocated—
Extra debt within 2.5× EBITDA—
Interest coverage3.70×
Limit utilisation84%
Open bank charges0 · —
  • Credit outlook model: 79% chance the next rating action is stable or better
  • Current rating BB+ (below investment grade)
  • Interest coverage 3.7×
  • Working-capital limits 84% utilised on average
  • Issuer not cooperating with the rating agency

What happened, step by step

Refinanced bank debt with equity
  1. Oct 2018 — ₹3.3 cr raised through equity
  2. Oct 2018 — Rated term loans fell from ₹58.34 cr to ₹0 cr

“The gearing levels improved on account of infusion of equity of Rs. 3.30 cr in FY18 and accretion of surplus to net worth.”

Capex funded with bank debt
  1. Jun 2026 — Project / plant of ₹676.26 cr
  2. Jun 2026 — Term debt tied up

“The project cost of ₹676.26 crore was to be funded through a debt-equity mix of ₹441.45 crore (~65%), and ₹235.01 crore (~35%) respectively.”

Rated limits by facility

Timeline

09 Jun 2026 CARE downgraded: BB+ (Stable)Rated limits ₹630.94 cr CARE rationale
09 Jun 2026 Capex / project: ₹676.26 cr
From the report

The project cost of ₹676.26 crore was to be funded through a debt-equity mix of ₹441.45 crore (~65%), and ₹235.01 crore (~35%) respectively.

CARE rationale
09 Jun 2026 Full repayment of debt (₹540 cr)
From the report

The company refinanced its existing term debt by repayment of outstanding debt through issuance of non-convertible debentures (NCDs) of ₹540 crore at a high interest rate (overall effective rate of interest of 16.95%).

CARE rationale
09 Jun 2026 New borrowing arranged (term loans)
From the report

However, debt coverage metrics moderated as reflected by total debt to GCA (TD/GCA) of 13.22x in FY26 (PY: 2.95x) because of sizable term debt availed for partly funding capex in Ayodhya, Uttar Pradesh.

CARE rationale
09 Jun 2026 Average working-capital utilisation 84%
From the report

The company has free cash and bank balance of ₹15.00 crore as on December 31, 2025, andaverage utilisation of fund-based working capital limits (based on maximum level) remained at ~84% in the past 12 month’s period ending December 2025.

CARE rationale
09 Jun 2026 Cash & liquid funds ₹15 cr
From the report

The company has free cash and bank balance of ₹15.00 crore as on December 31, 2025, andaverage utilisation of fund-based working capital limits (based on maximum level) remained at ~84% in the past 12 month’s period ending December 2025.

CARE rationale
06 Mar 2026 CARE downgraded: BBB- (Negative)Rated limits ₹630.94 cr CARE rationale
06 Mar 2026 New borrowing arranged (term loans)
From the report

However, total debt to GCA (TD/GCA) moderated to 2.95x in FY25 (PY: 2.86x) because of sizable term debt availed for partly funding capex in Ayodhya, Uttar Pradesh.

CARE rationale
06 Mar 2026 Capex / project: ₹676.26 cr
From the report

The project cost of ₹676.26 crore was to be funded through a debt-equity mix of ₹441.45 crore (~65%), and ₹235.01 crore (~35%) respectively.

CARE rationale
06 Mar 2026 Average working-capital utilisation 84%
From the report

The company has free cashand bank balance of ₹15.00 crore as on December 31, 2025, and average utilisation of fund-based working capital limits (based on maximum level) remained at ~84% in the past 12 month’s period ending December 2025.

CARE rationale
29 Apr 2025 CARE reaffirmed: BBB (Stable)Rated limits ₹630.94 cr CARE rationale
29 Apr 2025 New borrowing arranged: ₹125 cr (term loans)
From the report

This moderation is primarily due to new term loans of ₹125.00 crore (disbursed amount of ₹100.00 crore) availed for the partly debt-funded capex in Ayodhya, Uttar Pradesh.

CARE rationale
29 Apr 2025 ₹246.87 cr raised through equity
From the report

Term loans of ₹100.00 crore have been availed and equity of ₹173.43 crore infused in form of new issue, share warrants, and ESOP (share warrants are partly paid and amount of ₹73.44 crore yet to be received reaching total equity infusion to ₹246.87 crore and replacing internal accruals).

CARE rationale
29 Apr 2025 New borrowing arranged: ₹100 cr (equity)
From the report

Term loans of ₹100.00 crore have been availed and equity of ₹173.43 crore infused in form of new issue, share warrants, and ESOP (share warrants are partly paid and amount of ₹73.44 crore yet to be received reaching total equity infusion to ₹246.87 crore and replacing internal accruals).

CARE rationale
29 Apr 2025 Cash & liquid funds ₹53.54 cr
From the report

The company has healthy free cash and bank balance of ₹53.54 crore as on March 31, 2024 (PY: ₹0.77 crore) and healthy operational cash flow of ₹34.69 crore as on March 31, 2024 and strong current ratio of 1.98x as on March 31, 2024 (PY: 1.24x).

CARE rationale
29 Apr 2025 Average working-capital utilisation 49.7%
From the report

Average utilisation of working capital limits remains ~49.7% for the trailing nine months ending on February 2025.

CARE rationale
06 Jan 2025 CARE watch: BBB (Stable)Rated limits ₹468.94 cr CARE rationale
06 Jan 2025 ₹125 cr raised through equity
From the report

The project has now achieved the financial closure with partial equity infusion in form of new issue, share warrants and ESOP following partial debt tie-up of Rs.125.00 crore.

CARE rationale
06 Jan 2025 ₹246.87 cr raised through equity
From the report

The term loan of Rs.125.00 crore has been duly sanctioned by banks and equity of Rs.173.43 crore infused in form of new issue, share warrants and ESOP (share warrants are partly paid and amount of Rs.73.44 crore yet to be received reaching total equity infusion to Rs.246.87 crore and replacing internal accruals).

CARE rationale
06 Jan 2025 New borrowing arranged: ₹125 cr (equity)
From the report

The term loan of Rs.125.00 crore has been duly sanctioned by banks and equity of Rs.173.43 crore infused in form of new issue, share warrants and ESOP (share warrants are partly paid and amount of Rs.73.44 crore yet to be received reaching total equity infusion to Rs.246.87 crore and replacing internal accruals).

CARE rationale
06 Jan 2025 Cash & liquid funds ₹57.08 cr
From the report

Liquidity: Adequate The liquidity of the company remains adequate as reflected by sufficient cushion in accruals marked by projected gross cash accruals to the tune of Rs.57.08 crore in FY25 as against scheduled repayment of Rs.12.01 crore.

CARE rationale
06 Jan 2025 Cash & liquid funds ₹53.54 cr
From the report

Further, the company has healthy free cash & bank balance of Rs.53.54 crore as on March 31, 2024 (PY: Rs.0.77 crore) coupled with healthy operational cash flow of Rs.34.69 crore as onMarch 31, 2024 and strong current ratio of 1.98x as on March 31, 2024 (PY: 1.24x).

CARE rationale
07 Mar 2024 CARE watch: BBB (Developing)Rated limits ₹468.94 cr CARE rationale
07 Mar 2024 Cash & liquid funds ₹64.97 cr
From the report

Press Release Liquidity: Adequate The liquidity of the company remains adequate as reflected by projected gross cash accruals to the tune of Rs.64.97 cr in FY24 as against scheduled repayment of Rs.9.03 cr.

CARE rationale
07 Mar 2024 Cash & liquid funds ₹0.77 cr
From the report

The free cash & bank balance of Rs.0.77 cr, current ratio remained strong at 1.30x as on March 31, 2023 (PY: 1.12x).The company is projected to incur large size debt funded capex of Rs.670.0 crin FY24-FY26.

CARE rationale
06 Apr 2023 CARE reaffirmed: BBB (Stable)Rated limits ₹478.24 cr CARE rationale
06 Apr 2023 Cash & liquid funds ₹73.78 cr
From the report

Liquidity: Adequate: The liquidity position of the company is adequate as reflected by projected gross cash accruals to the tune of Rs.73.78 crore in FY24 (refers to the period from April 01 to March 31) against scheduled repayment of Rs.13.77 crore. 2 CARE Ratings Ltd.

CARE rationale
06 Apr 2023 Average working-capital utilisation 71%
From the report

Press Release Further, the average utilization of working capital borrowings stood ~71% for the trailing 12 months ended December 31, 2022.

CARE rationale
06 Apr 2023 Cash & liquid funds ₹2.17 cr
From the report

The company had free cash and bank balance to the tune of Rs.2.17 crore as on December 31, 2022.

CARE rationale
16 Feb 2023 CARE assigned: BBB (Stable)Rated limits ₹162.12 cr CARE rationale
16 Feb 2023 Cash & liquid funds ₹73.78 cr
From the report

Liquidity: Adequate: The liquidity position of the company is adequate as reflected by projected gross cash accruals to the tune of Rs.73.78 crore in FY24 (refers to the period from April 01 to March 31) against scheduled repayment of Rs.13.77 crore.

CARE rationale
16 Feb 2023 Average working-capital utilisation 71%
From the report

Further, the average utilization of working capital borrowings stood ~71% for the trailing 12 months ended December 31, 2022.

CARE rationale
16 Feb 2023 Cash & liquid funds ₹2.17 cr
From the report

The company had free cash and bank balance to the tune of Rs.2.17 crore as on December 31, 2022.

CARE rationale
30 Jul 2021 CARE withdrawn: BBB (Stable) CARE rationale
03 Feb 2021 CARE non-cooperating: BBB (Stable)Rated limits ₹410.46 cr CARE rationale
03 Feb 2021 Cash & liquid funds ₹4.07 cr
From the report

The cash and bank balance of the company stood at Rs. 4.07 crore as on March 31, 2020 and Rs. 3.50 crore as on September 30, 2020. 2 CARE Ratings Limited Press Release Analytical approach: Standalone Applicable Criteria Policy in respect of Non-cooperation by issuer CARE's criteria on rating outlook and credit watch CARE's policy on default recognition Liquidity Analysis of Non-Financial Sector CARE’s methodology for manufacturing companies CARE's rating methodology on financial ratios – Non-financial sector CARE's Rating Methodology- Paper Industry CARE's Rating Methodology- Short Term Instru

CARE rationale
03 Feb 2021 Rated term loans fell from ₹64.73 cr to ₹0 cr CARE rationale
22 Jan 2020 CARE reaffirmed: BBB (Stable)Rated limits ₹205.23 cr CARE rationale
22 Jan 2020 Cash & liquid funds ₹30 cr
From the report

Liquidity : Adequate The company is having an adequate liquidity characterized by sufficient cushion in cash accruals in the range of Rs.30 crores to Rs.40 crores vis-à-vis the repayment obligations of around Rs.15 crores.

CARE rationale
22 Jan 2020 Debt repayments due: ₹15 cr
From the report

Liquidity : Adequate The company is having an adequate liquidity characterized by sufficient cushion in cash accruals in the range of Rs.30 crores to Rs.40 crores vis-à-vis the repayment obligations of around Rs.15 crores.

CARE rationale
22 Jan 2020 Cash & liquid funds ₹0.13 cr
From the report

The free cash and bank balance of the company stood at Rs.0.13 crores in FY19 (PY: Rs.0.20 crores). 2 CARE Ratings Limited Press Release Analytical approach: Standalone Applicable Criteria Criteria on assigning ‘outlook’ and ‘credit watch’ CARE's Policy on Default Recognition Criteria for Short-term Instruments Rating Methodology-Manufacturing Companies Financial ratios - Non-Financial Sector About the Company Yash Pakka Limited (the name of the company was changed from Yash Papers Limited w.e.f.

CARE rationale
04 Oct 2018 CARE reaffirmed: BBB (Stable)Rated limits ₹403.6 cr CARE rationale
04 Oct 2018 ₹3.3 cr raised through equity
From the report

The gearing levels improved on account of infusion of equity of Rs. 3.30 cr in FY18 and accretion of surplus to net worth.

CARE rationale
04 Oct 2018 Average working-capital utilisation 87.76%
From the report

Further, the working capital utilization of the company remained high with average utilization of 87.76% for the past 12 months ending August 2018.

CARE rationale
04 Oct 2018 Rated term loans fell from ₹58.34 cr to ₹0 cr CARE rationale
04 Dec 2017 CARE reaffirmed: BBB- (Stable)Rated limits ₹165 cr CARE rationale
04 Dec 2017 New borrowing arranged: ₹54 cr (equity)
From the report

The total project cost incurred is Rs.54 crore funded through term loan of Rs.40.50 crore (already tied up) and equity / unsecured loan of Rs.13.5 crore.

CARE rationale
17 Nov 2017 CARE assigned: BBB- (Stable)Rated limits ₹165 cr CARE rationale
17 Nov 2017 New borrowing arranged: ₹54 cr (equity)
From the report

The total project cost incurred is Rs.54 crore funded through term loan of Rs.40.50 crore (already tied up) and equity / unsecured loan of Rs.13.5 crore.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered office312, PLAZA KALPANA SOCIETY,24/147, B-49,, KANPUR NAGAR, BIRHANA ROAD, UTTAR PRADESH, INDIA,, KANPUR, IN-UP, 208001
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.